Nausea was the most commonly reported adverse event with both agents, with slightly less persistent nausea in the liraglutide group than in the exenatide group.
两种药使用中报告频率最多的不良反应是呕吐，依拉鲁肽组相比依克那肽组持续呕吐的发生要稍轻些。
To design a new drug vector for promoting the agents across cellular membrane and releasing at the target issues is a persistent challenge.
构建一种药物载体使其能顺利穿透细胞膜并在靶向部位释放，已成为药物设计中亟需解决的问题之一。
To design a new drug vector for promoting the agents across cellular membrane and releasing at the target issues is a persistent challenge.
构建一种药物载体使其能顺利穿透细胞膜并在靶向部位释放，已成为药物设计中亟需解决的问题之一。
应用推荐